BioHealth News Archive
First GSK Ebola vaccine shipment due to arrive in Liberia – Reuters
The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday,…
Read More
Mid-America – Facilitating Venture Investments with the Leading Midwest Healthcare and Life Science Companies
March 10-11, 2015 - Chicago, IL INVESTORS & INDUSTRY UNITE MidAmerica Healthcare Venture Forum is the premier healthcare investing conference, uniting active investors with…
Read More
CHAPEL HILL: UNC-Chapel Hill creates $5 million startup fund – NewsObserver.com
UNC-Chapel Hill has created a $5 million fund to help startups commercialize technology developed at the university. The new Carolina Research Venture Fund, an…
Read More
Useful Stats Venture Capital Investment Dollars, Deals by State, 2009-2014 – SSTI
U.S. venture capital investment hit $48.3 billion in 2014, its highest level since 2000, according to data from the National Venture Capital Association (NVCA)…
Read More
5 keys to success that digital health tech startups simply can’t ignore – VentureBeat
With the surge in digital health tech, entrepreneurs who dream of developing the next killer healthcare app have plenty of reason to be optimistic.…
Read More
FTC Approves Novartis-GSK Deal; Former Asked to Divest Nicotine Patch Business
The Federal Trade Commission has finally approved the joint venture of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline Plc (ADR) (NYSE:GSK) in consumer health products,…
Read More
Biotech Regenxbio lands $30 million investment to pursue clinical trials – Washington Business Journal
District-based biotech company Regenxbio has raised a $30 million funding round to move its drugs into clinical trials. T he Washington Post reports the…
Read More
MedImmune forms partnership with National Cancer Institute – Baltimore Sun
MedImmune has formed a partnership with the National Cancer Institute to develop cancer therapies that use the immune system or attack tumor cells to…
Read More
AstraZeneca Supports Alderley Park Incubation Fund – Labmate Online
BioCity, the incubation specialist with locations in the East Midlands, North West and Scotland has announced a new investment fund, created following a significant…
Read More
2015 Annual Conference – The Community Development Venture Capital Alliance
CDVCA is organizing its 20th anniversary Annual Conference in Washington, DC on March 18-20, 2015 in Washington, DC. CDVCA’s Annual Conference is the premier…
Read More
Startup Maryland names first entrepreneur-in-residence – Baltimore Business Journal
Startup Maryland's first entrepreneur-in-residence is an old hand at helping startups create leadership dream teams. Shahab Kaviani, co-founder and CEO of CoFoundersLab in Rockville,…
Read More
BioIT Solutions among the 20 Most Promising Biotechnology Solutions for 2014 – BioIT Solutions
BioIT Solutions, a provider of enterprise systems built on the 1Platform4™ product suite, today announced that CIO Review has chosen BioIT Solutions as one of…
Read More
Germantown’s Intrexon Corp. opens up public offering worth up to $150 million – Washington Business Journal
Germantown-based Intrexon Corp. a synthetic biology company, plans to raise up to $150 million though a secondary offering of common stock, the company said…
Read More
With 30 Million REGENXBIO to Finance a Round of New Hires
Washington, D.C.-based REGENXBIO Inc., announced today that it had completed a $30 million Series C financing. The round was led by Enrick and Brookside…
Read More
AstraZeneca, Qiagen Continue to Advance Personalized Rx, CDx Partnership around Iressa – GenomeWeb
Following AstraZeneca's December announcement that it is taking steps to reintroduce the EGFR-targeted non-small cell lung cancer drug Iressa (gefitinib) in the US, Qiagen…
Read More